Skip Navigation


Cardiovascular Research Advance Access first published online on August 16, 2008
This version [Corrected Proof] published online on September 3, 2008
Cardiovascular Research, doi:10.1093/cvr/cvn228
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
80/3/339    most recent
cvn228v2
cvn228v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jin, D.
Right arrow Articles by Nagaya, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jin, D.
Right arrow Articles by Nagaya, N.
Related Collections
Right arrowRelated Article
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema

DongHao Jin1, Kazuhiko Harada2, Shunsuke Ohnishi1, Kenich Yamahara1, Kenji Kangawa2 and Noritoshi Nagaya1,*

1 Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan
2 Department of Biochemistry, National Cardiovascular Center Research Institute, Osaka, Japan

* Corresponding author. Tel: +81 6 6833 5012; fax: +81 6 6835 5496. E-mail address: nnagaya{at}hotmail.co.jp

Aims: Adrenomedullin (AM) is a multifunctional peptide hormone that plays a significant role in vasodilation and angiogenesis. Lymphoedema is a common but refractory disorder that is difficult to be treated with conventional therapy. We therefore investigated whether AM promotes lymphangiogenesis and improves lymphoedema.

Methods and results: The effects of AM on lymphatic endothelial cells (LEC) were investigated. AM promoted proliferation, migration, and network formation of cultured human lymphatic microvascular endothelial cells (HLMVEC). AM increased intracellular cyclic adenosine monophosphate (cAMP) level in HLMVEC. The cell proliferation induced by AM was inhibited by a cAMP antagonist and mitogen-activated protein kinase kinase (MEK) inhibitors. Phosphorylated extracellular signal-regulated kinase (ERK) in HLMVEC was increased by AM. Continuous administration of AM (0.05 µg/kg/min) to BALB/c mice with tail lymphoedema resulted in a decrease in lymphoedema thickness. AM treatment increased the number of lymphatic vessels and blood vessels in the injury site.

Conclusion: AM promoted LEC proliferation at least in part through the cAMP/MEK/ERK pathway, and infusion of AM induced lymphangiogenesis and improved lymphoedema in mice.

KEYWORDS Adrenomedullin; Lymphangiogenesis; Lymphoedema

Time for primary review: 13 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article

The third vasculature gets attention
Raimund Hirschberg
Cardiovasc Res 2008 80: 324-325. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
W. P. Dunworth and K. M. Caron
G Protein-Coupled Receptors as Potential Drug Targets for Lymphangiogenesis and Lymphatic Vascular Diseases
Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 650 - 656.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. Hirschberg
The third vasculature gets attention
Cardiovasc Res, December 1, 2008; 80(3): 324 - 325.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.